Copyright  2017 Advantagene, Inc.  All rights reserved. Made by AFP.    Terms of use | Privacy policy

Videos


Matt Futer, Glioblastioma survivor and clinical trial participant, Houston Methodist Hospital

2015 ASCO Annual Meeting (please note that you will need an ASCO username and password)

David S. Baskin, M.D., - Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy as Adjuvant to Surgical Resection for Newly Diagnosed Malignant Glioma

Discussion of "Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy as Adjuvant to Surgical Resection for Newly Diagnosed Malignant Glioma

Immunotherapy for Central Nervous System Tumors: Biomarkers and Novel Data

Testimonials